Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

NCT00003989

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • Universitaetsklinik Innsbruck, Austria
  • Kaiser Franz Josef Hospital Vienna (Wien), Austria
  • Institut Jules Bordet Brussels (Bruxelles), Belgium
  • Ludwig Institute for Cancer Research-Brussels Branch Brussels (Bruxelles), Belgium
View all 27 locations
View Trial Details
Completed

Paclitaxel in Treating Patients With Lung Cancer

NCT00002972

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Centre Hospitalier Regional de la Citadelle Liege (Luik), Belgium
  • University Thomayers' Hospital Krhanice, Czechia
  • Universitaetsklinik und Strahlenklinik - Essen Essen, Germany
  • Azienda Ospedale S. Luigi - Universita Di Torino Orbassano, (Torino), Italy
View Trial Details
Completed

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

NCT00003062

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy
  • Vrije Universiteit Medisch Centrum Amsterdam, Netherlands
  • Medical University of Gdansk Gdansk, Poland
  • Medical Oncology Centre of Rosebank Johannesburg, South Africa
View Trial Details
Completed

Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

NCT00002623

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • Algemeen Ziekenhuis Middelheim Antwerp, Belgium
  • A.Z. St. Jan Bruges, Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
  • Hopital de Jolimont Haine-Saint-Paul, Belgium
View all 30 locations
View Trial Details
Completed

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

NCT00094094

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Pfizer Investigational Site Irvine, California, United States
  • Pfizer Investigational Site Orange, California, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Park Ridge, Illinois, United States
View Trial Details
Completed

A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer

NCT00887549

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dublin, Ireland
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Derby, Derbyshire, United Kingdom
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Exeter, Devon, United Kingdom
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maidstone, Kent, United Kingdom
View all 14 locations
View Trial Details
Completed

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

NCT00367679

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Rancho Mirage, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Newark, Delaware, United States
View Trial Details

Related conditions